LRP2 and eye disorder: Although gene therapy has emerged as a promising approach to treat inherited eye diseases, it is difficult to rescue Lrp2 loss-of-function phenotypes by gene augmentation therapy given the large molecular weight of LRP2 (∼522 kDa).